適用金融は,予想より少し低い利益の中で,第2四半期にElevance Healthの株を14.9%削減しました. Applied Finance cut its Elevance Health stake by 14.9% in Q2 amid slightly below-expected earnings.

アプライド・ファイナンシャル・キャピタル・マネジメントは,第2四半期にエレバンス・ヘルス (ELV) の株式を14.9%削減し,481株を売却し,1,070万ドルの価値の2,756株を保有しました. Applied Finance Capital Management LLC reduced its stake in Elevance Health (ELV) by 14.9% in Q2, selling 481 shares and holding 2,756 shares valued at $1.07 million. 同社は1株あたり8.84円のQ2収益を9.30ドルより少し下回ると報告し,同社は年収が14.3パーセント上昇,49.42億円に上昇した. The company reported Q2 earnings of $8.84 per share, slightly below the $9.30 estimate, while revenue rose 14.3% year-over-year to $49.42 billion. スザン・D・デボレ監督は312.15ドルで1200株を購入し、3502株に増額し,約1億9900万ドルの価値を増した. Director Susan D. Devore bought 1,200 shares at $312.15, increasing her stake to 3,502 shares worth about $1.09 million. 株式は348.14ドルで,78. 39億円の市場キャップと,P/E/1414の比率で閉鎖された. The stock closed at $348.14 with a market cap of $78.39 billion and a P/E ratio of 14.81. アナリストは,目標価格408.33ドルの"適度な買い"の評価に合意している. Analysts have a consensus “Moderate Buy” rating with a target price of $408.33.